SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act
July 15, 2014
Date of Report (Date of Earliest Event Reported)
MediJane Holdings, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
| Nevada |
| 333-167275 |
| 46-0525378 |
| (State or other jurisdiction of incorporation or organization) |
| (Commission File Number) |
| (I.R.S. Employer Identification Number) |
|
|
|
|
| 2011 Ken Pratt Blvd, Suite 210 |
|
|
| Longmont, CO |
| 80501 |
| (Address of principal executive offices) |
| (Zip Code) |
(855) 933-3499
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors
On July 15, 2014, Dr. Joe Cohen resigned from his position as director and as chief medical officer for the registrant.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
MediJane Holdings, Inc.
| By: | /s/ Ronald Lusk |
|
|
| Ronald Lusk |
|
Dated: July 17, 2014